FIELD: medicine.
SUBSTANCE: invention refers to medicine. There are described Transdermal Therapeutic Systems having a silicone adhesive layer, and a method for producing and using them.
EFFECT: transdermal therapeutic systems provide achieving a certain plasma concentration.
23 cl, 3 tbl, 4 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING ASENAPINE | 2019 |
|
RU2798017C2 |
| THERMOFUSIBLE TTS FOR APPLYING ROTIGOTIN | 2003 |
|
RU2304434C2 |
| TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING LAVAND OIL | 2015 |
|
RU2695785C2 |
| DEVICE FOR TRANSDERMAL INTRODUCTION OF ROTIGOTINE IN ORGANISM IN FORM OF BASE | 2003 |
|
RU2340339C2 |
| TRANSDERMAL ADMINISTRATION OF MEMANTINE | 2011 |
|
RU2578971C2 |
| TOLTERODIN-CONTAINING TRANSDERMAL THERAPEUTIC SYSTEM (TTS) | 2000 |
|
RU2251413C2 |
| TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING AZENAPINE AND POLYSILOXANE OR POLYISOBUTYLENE | 2017 |
|
RU2764443C2 |
| TRANSDERMAL THERAPEUTIC SYSTEM FOR TRANSDERMAL INJECTION OF GUANFACINE, CONTAINING SILICONE POLYMER | 2018 |
|
RU2792822C2 |
| TRANSDERMAL THERAPEUTIC SYSTEM FOR TRANSDERMAL ADMINISTRATION OF GUANFACINE CONTAINING AT LEAST ONE EXCIPIENT | 2018 |
|
RU2812734C2 |
| TRANSDERMAL GRANISETRON | 2004 |
|
RU2355387C2 |
